Melanotan II and tanning peptides: what TikTok gets wrong

What's this video probably claiming?

Based on the caption, hashtags, and creator context, @evilfemboyjames appears to be showing off a visible tan and crediting it to a tanning peptide, almost certainly Melanotan II (MT-II) or possibly afamelanotide, both of which stimulate melanin production by activating melanocortin receptors. The goth aesthetic framing is deliberate irony: a self-described goth getting a tan from a peptide is the joke. But the underlying claim, that an injectable or nasal peptide can produce a real, visible tan without significant UV exposure, is exactly the kind of thing that gets repeated on TikTok without any of the safety context that should accompany it. Melanotan II is not approved by the FDA for any indication. It is not a licensed cosmetic product. It circulates entirely in the grey-market research chemical space, and that matters for anyone watching this and thinking about trying it themselves.

What does the science actually show?

Melanotan II does produce measurable increases in skin pigmentation. That part is real. It works as a potent, non-selective melanocortin receptor agonist, hitting MC1R, MC3R, MC4R, and MC5R, which is exactly why its side effect profile is so broad. A clinical study by Dorr et al. (1996, Journal of Clinical Endocrinology and Metabolism) demonstrated dose-dependent increases in skin pigmentation with 0.025 mg/kg doses, along with significant rates of nausea, facial flushing, and spontaneous erections from MC4R activation. A later trial by Wessells et al. (1998, Urology) confirmed the erectile side effect so reliably that afamelanotide, a stabler analogue, was eventually developed and approved in the EU and US as Scenesse for erythropoietic protoporphyria, not for tanning. The pigmentation effect is real. The safety profile of the unregulated product people are actually using is not.

Where does the social media noise diverge from clinical reality?

TikTok tanning peptide content almost universally skips three things: the melanoma signal, the nausea burden, and the sourcing problem. On melanoma, a 2018 review by Haylett et al. in Experimental Dermatology flagged legitimate concern that MC1R stimulation without adequate photoprotection could accelerate progression of existing atypical nevi, though causation in humans has not been definitively established. That uncertainty is not the same as safety. On nausea, the Dorr 1996 trial reported nausea in over 80 percent of subjects at active doses. People posting tans on TikTok are not posting about two hours of post-injection nausea. On sourcing, grey-market MT-II has no standardized manufacturing, no sterility guarantees, and no verified peptide concentration. A 2021 product analysis cited in a UK Medicines and Healthcare products Regulatory Agency warning found significant dosing inconsistencies across unregulated batches. Showing a tan result without any of this context is selective to the point of being misleading.

What should you actually know?

If you are watching a TikTok of someone showing a tan they attribute to a peptide and thinking about sourcing one yourself, stop and read this part carefully. Melanotan II is not approved for human use in the US, UK, EU, Canada, or Australia. Purchasing it means buying an unregulated product of unknown purity and concentration. The visible tan in videos like this is real, but it comes with a side effect profile that includes nausea, blood pressure changes, involuntary erections, and an unresolved question about mole and nevus changes that no responsible clinician will wave away. The only legally available melanocortin-based therapy for pigmentation-related conditions is afamelanotide, prescribed under brand name Scenesse for a specific rare disease. Legitimate telehealth platforms do not prescribe Melanotan II. If a provider or online pharmacy is offering it to you, that is a regulatory red flag, not a medical service.